Searched for
PHARMA BUYOUT DEALS
Dealmaking stays strong as startup M&A momentum carries into 2026Indian startups are experiencing a surge in M&A exits, particularly in consumer, fintech, and ecommerce sectors, signalling a robust recove...- Organon gives Sun Pharma scale and reach, but challenge lies in integration, executionSun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It ...
- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- Sun Pharma deal structurally strong, debt the only overhang: Amit KhuranaMarket expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma's acquisition is seen as strategically ...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- 71% prefer majority control; 78% favour unlisted targets: IVCA–Aurum Survey signals structural shift in India’s buyout marketIndia's buyout market is evolving. Majority control is now preferred in deals. Family business succession and founder exits are driving act...
- Health makes wealth, says Equirus, as healthcare fundraising crosses pre-Covid high of Rs 62,432 croreIndia’s healthcare and life sciences sector has surpassed its Covid-era fundraising peak, with inflows crossing Rs 62,432 crore, says Equir...
- ChrysCapital sets sights on pharma buyout dealsChrysCapital, led by MD Kshitij Sheth, aims to acquire Indian companies in the formulation business with potential valuations of $200 milli...
- Cipla stake sale plan faces hurdle as promoters differ on valuation: ReportCipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute amo...
- Torrent Pharma, JB Chemicals in final race to acquire Curatio HealthcareDr Reddy's Laboratories is also understood to have made to the penultimate round of bidding process, people with direct knowledge of the ma...
- Dr Reddy's, Biocon among 6 drug companies in race for CuratioThe second round of bids are expected by March-end, the sources said. Investment banks Edelweiss and Mape Advisory are running the sale pro...
- Current headwinds to help shape M&A contours for Indian pharmaDrugmakers have reported impairments, reduced revenue guidance, or stretched the payback time.
- Sun Pharma in race for UK buyout in hospital-initiated & emergency care segmentSun Pharma is eyeing a controlling stake in UK based Bolt Equity Limited which is backed by AAC Capital.
- KKR likely to buy Gland Pharma for Rs 1,000 crore by month-endGland Pharma promoters and vice chairman Ravi Penmetsa and Sanjay Nayar, MD and chief executive officer of KKR declined comments.
- Mitsui in talks to invest Rs 250 crore in ClarisSources said the Japanese group's healthcare company might pick up stake from private equity players invested in Claris or invest in a join...
- South Africa-based Adcock Ingram buys Cosme Farma for Rs 480 croreSouth Africa-based drug maker Adcock Ingram has quietly acquired privately-held Cosme Farma for Rs 480 crore, a 13 times premium over Cosme...
- Sun Pharma to buy Taro for $454 mnSecond-largest overseas buyout by an Indian pharma company will give Sun an edge in North America where Israeli generics player records 90%...
Load More
